DOG:ARCA-ProShares Short Dow30 (USD)

ETF | Trading--Inverse Equity | NYSE Arca

Last Closing

USD 28.64

Change

0.00 (0.00)%

Market Cap

USD 0.31B

Volume

1.94M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

The investment seeks daily investment results, before fees and expenses, that correspond to the inverse (-1x) of the daily performance of the Dow Jones Industrial AverageSM. The fund invests in derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as the inverse (-1x) of the daily return of the index. The index is a price-weighted index and includes 30 large-cap, "blue-chip" U.S. stocks, excluding utility and transportation companies. The fund is non-diversified.

Inception Date: 19/06/2006

Primary Benchmark: DJ Industrial Average TR USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 0.97%

Management Expense Ratio: 0.95 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-03 )

Largest Industry Peers for Trading--Inverse Equity

Symbol Name Mer Price(Change) Market Cap
SH ProShares Short S&P500 0.89 %

N/A

USD 0.93B
SOXS Direxion Daily Semiconductor B.. 0.97 %

N/A

USD 0.67B
PSQ ProShares Short QQQ 0.95 %

N/A

USD 0.67B
SPXU ProShares UltraPro Short S&P50.. 0.91 %

N/A

USD 0.51B
SDOW ProShares UltraPro Short Dow30 0.95 %

N/A

USD 0.30B
SPDN Direxion Daily S&P 500® Bear .. 0.45 %

N/A

USD 0.17B
FNGD MicroSectors FANG+ Index -3X I.. 0.00 %

N/A

USD 0.14B
RWM ProShares Short Russell2000 0.95 %

N/A

USD 0.14B
YANG Direxion Daily FTSE China Bear.. 1.02 %

N/A

USD 0.12B
LABD Direxion Daily S&P Biotech Bea.. 1.00 %

N/A

USD 0.10B

ETFs Containing DOG

N/A

Market Performance

  Market Performance vs. Industry/Classification (Trading--Inverse Equity) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -3.57% 85% B 24% F
Dividend Return 2.42% 64% D 56% F
Total Return -1.15% 87% B+ 25% F
Trailing 12 Months  
Capital Gain -10.30% 75% C 18% F
Dividend Return 4.77% 75% C 67% D+
Total Return -5.54% 75% C 20% F
Trailing 5 Years  
Capital Gain -48.24% 91% A- 11% F
Dividend Return 4.60% 87% B+ 13% F
Total Return -43.64% 91% A- 10% F
Average Annual (5 Year Horizon)  
Capital Gain -10.34% 30% F 8% B-
Dividend Return -9.24% 30% F 8% B-
Total Return 1.10% 77% C+ 25% F
Risk Return Profile  
Volatility (Standard Deviation) 21.19% 86% B+ 49% F
Risk Adjusted Return -43.62% 21% F 9% A-
Market Capitalization 0.31B 74% C 34% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.